North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Fezolinetant
found
3 matches
Open monograph to display formulary status
BNF Category
Fezolinetant
(Veoza
®
)
Endocrine system - Hormone replacement therapy - 06.04.01.01
Links
Link to Drug Section
Link to document
MHRA DSU: Fezolinetant▼(Veoza): risk of liver injury; new recommendations to minimise risk, April 2025 (06.04.01.01)
NICE TA1143: Fezolinetant for treating moderate to severe vasomotor symptoms associated with menopause (06.04.01.01)
